163 related articles for article (PubMed ID: 11167739)
1. Cytogenetically cryptic AML1-ETO and CBF beta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia.
Rowe D; Cotterill SJ; Ross FM; Bunyan DJ; Vickers SJ; Bryon J; McMullan DJ; Griffiths MJ; Reilly JT; Vandenberghe EA; Wilson G; Watmore AE; Bown NP
Br J Haematol; 2000 Dec; 111(4):1051-6. PubMed ID: 11167739
[TBL] [Abstract][Full Text] [Related]
2. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
Mrózek K; Prior TW; Edwards C; Marcucci G; Carroll AJ; Snyder PJ; Koduru PR; Theil KS; Pettenati MJ; Archer KJ; Caligiuri MA; Vardiman JW; Kolitz JE; Larson RA; Bloomfield CD
J Clin Oncol; 2001 May; 19(9):2482-92. PubMed ID: 11331327
[TBL] [Abstract][Full Text] [Related]
3. A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
Langabeer SE; Grimwade D; Walker H; Rogers JR; Burnett AK; Goldstone AH; Linch DC
Br J Haematol; 1998 May; 101(2):338-40. PubMed ID: 9609531
[TBL] [Abstract][Full Text] [Related]
4. Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
Viswanatha DS; Chen I; Liu PP; Slovak ML; Rankin C; Head DR; Willman CL
Blood; 1998 Mar; 91(6):1882-90. PubMed ID: 9490670
[TBL] [Abstract][Full Text] [Related]
5. Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?
Marcucci G; Caligiuri MA; Bloomfield CD
Eur J Haematol; 2003 Sep; 71(3):143-54. PubMed ID: 12930314
[TBL] [Abstract][Full Text] [Related]
6. Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
Dissing M; Le Beau MM; Pedersen-Bjergaard J
J Clin Oncol; 1998 May; 16(5):1890-6. PubMed ID: 9586906
[TBL] [Abstract][Full Text] [Related]
7. Detection of CBFB/MYH11 transcripts in patients with inversion and other abnormalities of chromosome 16 at presentation and remission.
Tobal K; Johnson PR; Saunders MJ; Harrison CJ; Liu Yin JA
Br J Haematol; 1995 Sep; 91(1):104-8. PubMed ID: 7577615
[TBL] [Abstract][Full Text] [Related]
8. Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
Ichikawa H; Tanabe K; Mizushima H; Hayashi Y; Mizutani S; Ishii E; Hongo T; Kikuchi A; Satake M
Br J Haematol; 2006 Nov; 135(3):336-47. PubMed ID: 16989659
[TBL] [Abstract][Full Text] [Related]
9. Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.
Mitterbauer M; Kusec R; Schwarzinger I; Haas OA; Lechner K; Jaeger U
Ann Hematol; 1998; 76(3-4):139-43. PubMed ID: 9619731
[TBL] [Abstract][Full Text] [Related]
10. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia.
de Greef GE; Hagemeijer A; Morgan R; Wijsman J; Hoefsloot LH; Sandberg AA; Sacchi N
Leukemia; 1995 Feb; 9(2):282-7. PubMed ID: 7869765
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
Perea G; Lasa A; Aventín A; Domingo A; Villamor N; Queipo de Llano MP; Llorente A; Juncà J; Palacios C; Fernández C; Gallart M; Font L; Tormo M; Florensa L; Bargay J; Martí JM; Vivancos P; Torres P; Berlanga JJ; Badell I; Brunet S; Sierra J; Nomdedéu JF;
Leukemia; 2006 Jan; 20(1):87-94. PubMed ID: 16281071
[TBL] [Abstract][Full Text] [Related]
12. Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions.
Gamerdinger U; Teigler-Schlegel A; Pils S; Bruch J; Viehmann S; Keller M; Jauch A; Harbott J
Genes Chromosomes Cancer; 2003 Mar; 36(3):261-72. PubMed ID: 12557226
[TBL] [Abstract][Full Text] [Related]
13. Detection of the chromosome 16 CBF beta-MYH11 fusion transcript in myelomonocytic leukemias.
Poirel H; Radford-Weiss I; Rack K; Troussard X; Veil A; Valensi F; Picard F; Guesnu M; Leboeuf D; Melle J
Blood; 1995 Mar; 85(5):1313-22. PubMed ID: 7858261
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
Shurtleff SA; Meyers S; Hiebert SW; Raimondi SC; Head DR; Willman CL; Wolman S; Slovak ML; Carroll AJ; Behm F
Blood; 1995 Jun; 85(12):3695-703. PubMed ID: 7780153
[TBL] [Abstract][Full Text] [Related]
15. Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party.
Langabeer SE; Walker H; Rogers JR; Burnett AK; Wheatley K; Swirsky D; Goldstone AH; Linch DC
Br J Haematol; 1997 Dec; 99(4):925-8. PubMed ID: 9432044
[TBL] [Abstract][Full Text] [Related]
16. Detection of the CBFB/MYH11 fusion gene in de novo acute myeloid leukemia (AML): a single-institution study of 224 Japanese AML patients.
Monma F; Nishii K; Shiga J; Sugahara H; Lorenzo F; Watanabe Y; Kawakami K; Hosokai N; Yamamori S; Katayama N; Shiku H
Leuk Res; 2007 Apr; 31(4):471-6. PubMed ID: 17052753
[TBL] [Abstract][Full Text] [Related]
17. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
18. Molecular and clinical advances in core binding factor primary acute myeloid leukemia: a paradigm for translational research in malignant hematology.
Marcucci G; Caligiuri MA; Bloomfield CD
Cancer Invest; 2000; 18(8):768-80. PubMed ID: 11107447
[TBL] [Abstract][Full Text] [Related]
19. FISH identifies inv(16)(p13q22) masked by translocations in three cases of acute myeloid leukemia.
Dierlamm J; Stul M; Vranckx H; Michaux L; Weghuis DE; Speleman F; Selleslag D; Kramer MH; Noens LA; Cassiman JJ; Van den Berghe H; Hagemeijer A
Genes Chromosomes Cancer; 1998 Jun; 22(2):87-94. PubMed ID: 9598794
[TBL] [Abstract][Full Text] [Related]
20. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
